Synapse - Dmitriy Zamarin

Results (201)

Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16/CA-125-expressing malignancies

Journal Article

Stasenko, M.; Smith, E.; Yeku, O.; Park, K. J.; Laster, I.; Lee, K.; Walderich, S.; Spriggs, E.; Rueda, B.; Weigelt, B.; more...
Scientific Reports (2021)

Fulltext@MSK | Save

A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers

Journal Article

Rubinstein, M. M.; Grisham, R. N.; Cadoo, K.; Kyi, C.; Tew, W. P.; Friedman, C. F.; O'Cearbhaill, R. E.; Zamarin, D.; Zhou, Q.; Iasonos, A.; more...
Gynecologic Oncology (2021)

Fulltext@MSK | Save

Enhancement of the therapeutic effects of oncolytic vaccinia virus by using autologous and allogeneic cell-based delivery platforms

Meeting Abstract

Minev, B.; Santidrian, A. F.; Minev, I.; Nguyen, D.; Zamarin, D.; Marincola, F.; Draganov, D. D.
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Pattern of disease in recurrent cervical cancer associated with response to pembrolizumab

Meeting Abstract

Miller, K.; Filippova, O. T.; Hayes, S. A.; Abu-Rustum, N.; Aghajanian, C.; Broach, V.; Ellenson, L. H.; Jewell, E. L.; Kyi, C.; Lakhman, Y.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Evaluation of the potential of oncolytic vaccinia virus delivered by autologous SVF to modulate innate and adaptive immunity in patients with diverse solid and hematological malignancies

Meeting Abstract

Draganov, D.; Santidrian, A.; Minev, I.; Nguyen, D.; Zamarin, D.; Marincola, F.; Butterfield, L.; Minev, B.
Cancer Research (2020)

Fulltext@MSK | Save

CDK12 alterations define a distinct molecular subtype of prostate cancers with unique genomic and clinical characteristics

Meeting Abstract

Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H.; Kantoff, P. W.; Gopalan, A.; more...
Cancer Research (2020)

Fulltext@MSK | Save

Tim-4(+) resident macrophages impair anti-tumor immunity in the serous body cavities by sequestering viable and cytotoxic CD8(+) T cells expressing high levels of phosphatidylserine

Meeting Abstract

Chow, A.; Schad, S.; Green, M.; Hellmann, M.; Ceglia, N.; Allaj, V.; Zago, G.; Shah, N.; Sharma, S.; Mattar, M.; more...
Journal for ImmunoTherapy of Cancer (2020)

Fulltext@MSK | Save

Cytokine and immune subset signatures in patients with various solid and hematological malignancies treated with oncolytic vaccinia virus delivered by autologous stromal vascular fraction cells

Meeting Abstract

Draganov, D.; Santidrian, A.; Minev, I.; Nguyen, D.; Zamarin, D.; Marincola, F.; Minev, B.
Journal for ImmunoTherapy of Cancer (2020)

Fulltext@MSK | Save

Distinct immune signatures predicting clinical response to PD-1 blockade therapy in gynecological cancers revealed by high-dimensional immune profiling

Meeting Abstract

Muroyama, Y.; Muroyama, Y.; Manne, S.; Huang, A.; Mathew, D.; Chilukuri, L.; Greenplate, A.; Ohtani, T.; Zamarin, D.; Friedman, C.; more...
Journal for ImmunoTherapy of Cancer (2020)

Fulltext@MSK | Save

T cell intrinsic DNA damage and repair response as a novel marker associated with clinical response to PD-1 blockade

Meeting Abstract

Muroyama, Y.; Huang, A. C.; Manne, S.; Herati, R. S.; Mathew, D.; Xu, C.; Chilukuri, L.; Zamarin, D.; Friedman, C. F.; Wherry, E. J.
Journal of Immunology (2020)

Fulltext@MSK | Save